Syringe Maker ApiJect Reels in $111 Million in Private Investment Round
ApiJect, which was founded in 2015 to make safe, cheap prefilled syringes for developing countries, hauled in $111 million in a private round of investment.
Funds from the round, which was led by Royalty Pharma and Jefferies Financial, are slated for ongoing development of ApiJect’s blow-fill-seal (BFS) plastic profiled injection system and other “general working capital” purposes, the company said.
ApiJect’s system was invented by Marc Koska, a social entrepreneur who worked for decades in developing countries to prevent deaths from the reuse of contaminated needles. The company touts the tech as a low-cost “compact, prefilled, single-dose ‘soft’ syringe—manufactured using” BFS technology.